The EMT is often activated during cancer progression and may promote resistance to therapy, which is regulated by a variety of signaling pathways, including transforming growth factor-beta (TGFβ), hepatocyte growth factor (HGF), platelet derived growth factor (PDGF), and epidermal growth factor (EGF). The gene discussed is EGF; the disease is cancer.